Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio.
about
Chalcone Scaffold in Anticancer Armamentarium: A Molecular InsightHybrid curcumin compounds: a new strategy for cancer treatment.Chalcone-Induced Apoptosis through Caspase-Dependent Intrinsic Pathways in Human Hepatocellular Carcinoma CellsSL4, a chalcone-based compound, induces apoptosis in human cancer cells by activation of the ROS/MAPK signalling pathway.Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS.Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance.Coumarin-chalcone hybrid instigates DNA damage by minor groove binding and stabilizes p53 through post translational modifications.RECK inhibits cervical cancer cell migration and invasion by promoting p53 signaling pathway.Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis.Expression of Cyt-c-Mediated Mitochondrial Apoptosis-Related Proteins in Rat Renal Proximal Tubules during Development.
P2860
Q26765928-90A14612-D457-41BC-B0F8-1BE5636D01F8Q38290418-EE1E3545-5401-4F67-8F2D-37239B947B87Q38791626-5A16A122-FD9B-47AB-AEDF-71571F8CB132Q38825003-03BC1EA5-39AA-44E5-BEAB-2EC8D14D0116Q38903188-543D266E-3A06-4B4D-98CB-B3C4DC3EA4E1Q41836725-20C6FD37-C822-4EE6-8BCA-F0A6DC71D47FQ42371971-09E5E3A3-AC57-48D8-95CF-8EFCE4753EFDQ47610820-78156A25-306A-4D86-99F1-E43ADD38B020Q52716859-4A827697-ED74-4E75-BF20-D73A41772202Q54386966-5DC76C3F-809B-4CD0-BDFE-A927AD7883FE
P2860
Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Anti-tumour activity of a nove ...... and altering Bax/Bcl-2 ratio.
@en
Anti-tumour activity of a nove ...... and altering Bax/Bcl-2 ratio.
@nl
type
label
Anti-tumour activity of a nove ...... and altering Bax/Bcl-2 ratio.
@en
Anti-tumour activity of a nove ...... and altering Bax/Bcl-2 ratio.
@nl
prefLabel
Anti-tumour activity of a nove ...... and altering Bax/Bcl-2 ratio.
@en
Anti-tumour activity of a nove ...... and altering Bax/Bcl-2 ratio.
@nl
P2093
P2860
P1433
P1476
Anti-tumour activity of a nove ...... and altering Bax/Bcl-2 ratio.
@en
P2093
Jayanta Sarkar
Koneni V Sashidhara
Neetu Singh
Shakir Ali
Sudhir Sinha
P2860
P2888
P304
P356
10.1007/S10495-014-0975-2
P577
2014-06-01T00:00:00Z